Pub Date : 2020-12-31DOI: 10.36894/KCCA.2020.33.4.189
Jae-bum Kim
{"title":"The appropriateness of the director's compensation and the breach of the director' duty of loyalty","authors":"Jae-bum Kim","doi":"10.36894/KCCA.2020.33.4.189","DOIUrl":"https://doi.org/10.36894/KCCA.2020.33.4.189","url":null,"abstract":"","PeriodicalId":50646,"journal":{"name":"ACM Sigcomm Computer Communication Review","volume":"1 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69778236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"计算机科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-12-31DOI: 10.36894/KCCA.2020.33.4.107
S. Lim
{"title":"Obligation to pay insurance benefit for medical expenses in hospitals established by non-medical personnel","authors":"S. Lim","doi":"10.36894/KCCA.2020.33.4.107","DOIUrl":"https://doi.org/10.36894/KCCA.2020.33.4.107","url":null,"abstract":"","PeriodicalId":50646,"journal":{"name":"ACM Sigcomm Computer Communication Review","volume":"33 1","pages":"107-147"},"PeriodicalIF":2.8,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46816511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"计算机科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-12-31DOI: 10.36894/kcca.2020.33.4.151
Gang-hyeon An
{"title":"Article 69 of the Commercial Act and Liability for incomplete performance","authors":"Gang-hyeon An ","doi":"10.36894/kcca.2020.33.4.151","DOIUrl":"https://doi.org/10.36894/kcca.2020.33.4.151","url":null,"abstract":"","PeriodicalId":50646,"journal":{"name":"ACM Sigcomm Computer Communication Review","volume":"1 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69777897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"计算机科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Midline Destructive Syndrome (MDS) was first-described in 1897 [1]. It was not until 1922 when Stewart reported 10 cases of a chronic destructive process in the facial midline. Since then, there have been multiple ways to call the syndrome, including idiopathic midline granuloma, lethal midline granuloma, polymorphic reticulosis, and Stewart's syndrome, among others. This reflects the variability behavior and the lack of homogeneous nomenclature [2]. Abstract
{"title":"Midline Destructive Syndrome in a Patient with HIV, Case Report, Review and Approach Proposal","authors":"Salgado E, Gamas A, P. B, F. G., R. R, Valverde A","doi":"10.46527/2582-5038.177","DOIUrl":"https://doi.org/10.46527/2582-5038.177","url":null,"abstract":"Midline Destructive Syndrome (MDS) was first-described in 1897 [1]. It was not until 1922 when Stewart reported 10 cases of a chronic destructive process in the facial midline. Since then, there have been multiple ways to call the syndrome, including idiopathic midline granuloma, lethal midline granuloma, polymorphic reticulosis, and Stewart's syndrome, among others. This reflects the variability behavior and the lack of homogeneous nomenclature [2]. Abstract","PeriodicalId":50646,"journal":{"name":"ACM Sigcomm Computer Communication Review","volume":"1 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2020-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70557196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"计算机科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: To explore the feasibility of MRU (Magnetic Resonance Urography) under the intravenous injection of furosemide (FRS) in the diagnosis of abnormal hydronephrosis caused by renal pelvis and ureteral junctions during the intermittent period, though a 1.5T magnetic resonance scanner. Study Design: Clinical research. Place and Duration of Study: Department of Radiology and Urology, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China, from April to September 2019. Methods: Twenty-four children, with symptomatic hydronephrosis caused by abnormal pelvic ureteral junctions during the intermittent period, were scanned by MRU after the first static hydration and the second intravenous injection of FRS, and contrast with ultrasound (US) results. Then comparison with the pathological results for who undergoing surgical treatment. The US and MRU image development was evaluated on a 4-point scale for renal pelvis and ureter development, and the overall situation was evaluated on a 5-point scale. Results: BUS had 70.8% sensitivity of hydronephrosis, 16.7% sensitivity of ureteral dilatation, and overall sensitivity of 70.8%. The sensitivity of the three indexes in the hydraulic group was 87.5%, 95.8% and 100%, respectively. For the FRS group, the sensitivity increased to 100%, and when comparison with the pathological results from the 13 out of 24 cases underwent surgical treatment, the positive rate of coincidence was 77%. www.yumedtext.com | December-2020 | ISSN: 2582-5038 | https://dx.doi.org/10.46527/2582-5038.174
{"title":"MRU Imaging after Infection of Furosemide for the Accuracy Diagnosis of Symptomatic Hydronephrosis","authors":"X. Jia, Chen Zhongyu, C. Guangjie","doi":"10.46527/2582-5038.174","DOIUrl":"https://doi.org/10.46527/2582-5038.174","url":null,"abstract":"Objectives: To explore the feasibility of MRU (Magnetic Resonance Urography) under the intravenous injection of furosemide (FRS) in the diagnosis of abnormal hydronephrosis caused by renal pelvis and ureteral junctions during the intermittent period, though a 1.5T magnetic resonance scanner. Study Design: Clinical research. Place and Duration of Study: Department of Radiology and Urology, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China, from April to September 2019. Methods: Twenty-four children, with symptomatic hydronephrosis caused by abnormal pelvic ureteral junctions during the intermittent period, were scanned by MRU after the first static hydration and the second intravenous injection of FRS, and contrast with ultrasound (US) results. Then comparison with the pathological results for who undergoing surgical treatment. The US and MRU image development was evaluated on a 4-point scale for renal pelvis and ureter development, and the overall situation was evaluated on a 5-point scale. Results: BUS had 70.8% sensitivity of hydronephrosis, 16.7% sensitivity of ureteral dilatation, and overall sensitivity of 70.8%. The sensitivity of the three indexes in the hydraulic group was 87.5%, 95.8% and 100%, respectively. For the FRS group, the sensitivity increased to 100%, and when comparison with the pathological results from the 13 out of 24 cases underwent surgical treatment, the positive rate of coincidence was 77%. www.yumedtext.com | December-2020 | ISSN: 2582-5038 | https://dx.doi.org/10.46527/2582-5038.174","PeriodicalId":50646,"journal":{"name":"ACM Sigcomm Computer Communication Review","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2020-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47993999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"计算机科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Bayati, Thena J Al Khishali, Mohanad Ma Al Bayati, Hameed Bm
Lunotriquetral coalition (LTC) is fusion of the lunate and triquetral bones of the carpus. LTC is most common accounting 90%, of all coalitions in the hand frequently bilateral, in unilateral cases mostly on the left side [1,2]. It can be between any carpal or metacarpal bones, but mostly in one row on the ulnar side. Incidence is 0.1% in Caucasian population, more in females with 2: 1 ratio. Incidence is higher in Africans, mostly in West African tribes up to 9%, 1 [3-5]. It is hereditary, dominant, autosomal linked condition of failure of cavitation of wrist cartilage, occur in the 4-8 months of gestational period. Coalition can be fibrous, cartilaginous, or osseous, complete, or partial. It appears on radiograph in early adulthood, from 6-14 years, with ossification of carpal bones. Abstract
{"title":"Lunotriquetral Coalition: Report of Two Different Cases","authors":"M. Bayati, Thena J Al Khishali, Mohanad Ma Al Bayati, Hameed Bm","doi":"10.46527/2582-5038.173","DOIUrl":"https://doi.org/10.46527/2582-5038.173","url":null,"abstract":"Lunotriquetral coalition (LTC) is fusion of the lunate and triquetral bones of the carpus. LTC is most common accounting 90%, of all coalitions in the hand frequently bilateral, in unilateral cases mostly on the left side [1,2]. It can be between any carpal or metacarpal bones, but mostly in one row on the ulnar side. Incidence is 0.1% in Caucasian population, more in females with 2: 1 ratio. Incidence is higher in Africans, mostly in West African tribes up to 9%, 1 [3-5]. It is hereditary, dominant, autosomal linked condition of failure of cavitation of wrist cartilage, occur in the 4-8 months of gestational period. Coalition can be fibrous, cartilaginous, or osseous, complete, or partial. It appears on radiograph in early adulthood, from 6-14 years, with ossification of carpal bones. Abstract","PeriodicalId":50646,"journal":{"name":"ACM Sigcomm Computer Communication Review","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2020-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49392641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"计算机科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The ideal anticoagulant in pregnancy and postpartum is yet to be found. Vitamin K antagonists are cumbersome to use having multiple interactions with food and other drugs, requiring frequent laboratory monitoring and necessitating switch over to heparin in early pregnancy and around delivery. Direct Oral Anticoagulants (DOAC) are now therapeutic alternatives to Warfarin in the management of venous thromboembolism, non-valvular atrial fibrillation, and acute coronary syndromes. Their use in pregnancy and the postpartum period is to be explored. Our case is a 35-year, third gravida with two living issues with Rheumatic heart disease (severe mitral and tricuspid regurgitation, moderate pulmonary artery hypertension and chronic atrial fibrillation). She presented at 18 weeks’ gestation with active bleeding from a low-lying placenta. This being an unwanted pregnancy, she underwent hysterotomy with bilateral tubal ligation. Post procedure, warfarin was initiated in view of her chronic atrial fibrillation, and slowly titrated to a target an INR of 2-3. She developed spontaneous haemoperitoneum on warfarin therapy, which was conservatively managed. After resolution of haemoperitoneum, attempting to establish adequate anticoagulation on heparin and warfarin prolonged her hospital stay by an additional 3 weeks of hospital stay until dabigatran was initiated and the patient could be discharged. DOACs offer several advantages efficacy, safety, predictable pharmacokinetics. Although category C drugs in pregnancy, as data accumulates on exposures of these drugs in pregnancy, they may be a future therapeutic option which avoids many of the problems associated with current anticoagulation regimes.
{"title":"Anticoagulation in Pregnancy and Post-partum: New Options","authors":"S. Rajan, Aparna K Sharma","doi":"10.46527/2582-5038.172","DOIUrl":"https://doi.org/10.46527/2582-5038.172","url":null,"abstract":"The ideal anticoagulant in pregnancy and postpartum is yet to be found. Vitamin K antagonists are cumbersome to use having multiple interactions with food and other drugs, requiring frequent laboratory monitoring and necessitating switch over to heparin in early pregnancy and around delivery. Direct Oral Anticoagulants (DOAC) are now therapeutic alternatives to Warfarin in the management of venous thromboembolism, non-valvular atrial fibrillation, and acute coronary syndromes. Their use in pregnancy and the postpartum period is to be explored. Our case is a 35-year, third gravida with two living issues with Rheumatic heart disease (severe mitral and tricuspid regurgitation, moderate pulmonary artery hypertension and chronic atrial fibrillation). She presented at 18 weeks’ gestation with active bleeding from a low-lying placenta. This being an unwanted pregnancy, she underwent hysterotomy with bilateral tubal ligation. Post procedure, warfarin was initiated in view of her chronic atrial fibrillation, and slowly titrated to a target an INR of 2-3. She developed spontaneous haemoperitoneum on warfarin therapy, which was conservatively managed. After resolution of haemoperitoneum, attempting to establish adequate anticoagulation on heparin and warfarin prolonged her hospital stay by an additional 3 weeks of hospital stay until dabigatran was initiated and the patient could be discharged. DOACs offer several advantages efficacy, safety, predictable pharmacokinetics. Although category C drugs in pregnancy, as data accumulates on exposures of these drugs in pregnancy, they may be a future therapeutic option which avoids many of the problems associated with current anticoagulation regimes.","PeriodicalId":50646,"journal":{"name":"ACM Sigcomm Computer Communication Review","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2020-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44863838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"计算机科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neeraj Salhotra, S. Laiq, C. Livingston, Mahmood Al Hattali, Hunaina Al Kindi, Zahra Al Hajri
Atypical teratoid/rhabdoid (AT/RT) tumor is a rare, highly malignant tumor of the central nervous system (CNS), most commonly found in children less than 5 years of age. Although the vast majority of cases are diagnosed in young children, there have been isolated case reports in adults. Since its histological appearance can be confused with other tumors, especially in adults, separating AT/RT from other neoplasms may be difficult. In many instances, a reliable diagnosis is not possible without demonstrating the lack of nuclear INI1 (SMARCB1) or BRG1 (SMARCA4) protein expression by immunohistochemical methods or by detection of somatic / germline mutation of the INI1 (SMARCB1) or BRG1 (SMARCA4) gene. Final diagnosis is confirmed after immunohistochemical analysis and/or molecular analysis. Immunohistochemical staining show that the tumor cells are positive for vimentin and reacted variably for keratin, epithelial membrane antigen (EMA), synaptophysin, neurofilament protein, CD34, and smooth muscle actin (SMA) and negative for GFAP, S-100, desmin and CD99. In adult examples of AT/RT, the diagnosis requires a high index of suspicion, with early tissue diagnosis and a low threshold for investigation with INI1 immunohistochemistry to differentiate this entity from other morphologically similar tumors. Although Abstract
{"title":"Atypical Teratoid/Rhabdoid Tumor in Adults an Uncommon Entity: A Case Report","authors":"Neeraj Salhotra, S. Laiq, C. Livingston, Mahmood Al Hattali, Hunaina Al Kindi, Zahra Al Hajri","doi":"10.46527/2582-5038.171","DOIUrl":"https://doi.org/10.46527/2582-5038.171","url":null,"abstract":"Atypical teratoid/rhabdoid (AT/RT) tumor is a rare, highly malignant tumor of the central nervous system (CNS), most commonly found in children less than 5 years of age. Although the vast majority of cases are diagnosed in young children, there have been isolated case reports in adults. Since its histological appearance can be confused with other tumors, especially in adults, separating AT/RT from other neoplasms may be difficult. In many instances, a reliable diagnosis is not possible without demonstrating the lack of nuclear INI1 (SMARCB1) or BRG1 (SMARCA4) protein expression by immunohistochemical methods or by detection of somatic / germline mutation of the INI1 (SMARCB1) or BRG1 (SMARCA4) gene. Final diagnosis is confirmed after immunohistochemical analysis and/or molecular analysis. Immunohistochemical staining show that the tumor cells are positive for vimentin and reacted variably for keratin, epithelial membrane antigen (EMA), synaptophysin, neurofilament protein, CD34, and smooth muscle actin (SMA) and negative for GFAP, S-100, desmin and CD99. In adult examples of AT/RT, the diagnosis requires a high index of suspicion, with early tissue diagnosis and a low threshold for investigation with INI1 immunohistochemistry to differentiate this entity from other morphologically similar tumors. Although Abstract","PeriodicalId":50646,"journal":{"name":"ACM Sigcomm Computer Communication Review","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2020-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49042156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"计算机科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hairy cell leukemia (HCL) is a rare indolent lymphoproliferative disorder clinically characterized by pancytopenia and splenomegaly [1], with high overall survival rates after treatment with purine analogues [2-4]. We report a relatively young patient with HCL presenting with widespread osteolytic disease detected by PET who was successfully treated with cladribine and ibandronate. Osteolyses are not considered a frequent complication of HCL [5] and we are aware of only one case report describing the use of PET for diagnostic purposes in this setting [6]. Resolution of bone lesions has been described after treatment with radiotherapy or cladribine [6-9], but to our knowledge, there are no data on the use of bisphosphonates in this context.
{"title":"Hairy Cell Leukemia Related Osteolyses Detected by PET Successfully Treated with Cladribine and Ibandronate","authors":"E. Ranković, A. Balenović, S. Dotlic, I. Aurer","doi":"10.46527/2582-5038.170","DOIUrl":"https://doi.org/10.46527/2582-5038.170","url":null,"abstract":"Hairy cell leukemia (HCL) is a rare indolent lymphoproliferative disorder clinically characterized by pancytopenia and splenomegaly [1], with high overall survival rates after treatment with purine analogues [2-4]. We report a relatively young patient with HCL presenting with widespread osteolytic disease detected by PET who was successfully treated with cladribine and ibandronate. Osteolyses are not considered a frequent complication of HCL [5] and we are aware of only one case report describing the use of PET for diagnostic purposes in this setting [6]. Resolution of bone lesions has been described after treatment with radiotherapy or cladribine [6-9], but to our knowledge, there are no data on the use of bisphosphonates in this context.","PeriodicalId":50646,"journal":{"name":"ACM Sigcomm Computer Communication Review","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2020-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45506103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"计算机科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Since the start of the COVID-19 pandemic, technology enthusiasts have pushed for digital contact tracing as a critical tool for breaking the COVID-19 transmission chains. Motivated by this push, many countries and companies have created apps that enable digital contact tracing with the goal to identify the chain of transmission from an infected individual to others and enable early quarantine. Digital contact tracing applications like AarogyaSetu in India, TraceTogether in Singapore, SwissCovid in Switzerland, and others have been downloaded hundreds of millions of times. Yet, this technology hasn't seen the impact that we envisioned at the start of the pandemic. Some countries have rolled back their apps, while others have seen low adoption [12, 17]. Therefore, it is prudent to ask what the technology landscape of contact-tracing looks like and what are the missing pieces. We attempt to undertake this task in this paper. We present a high-level review of technologies underlying digital contact tracing, a set of metrics that are important while evaluating different contact tracing technologies, and evaluate where the different technologies stand today on this set of metrics. Our hope is two fold: (a) Future designers of contact tracing applications can use this review paper to understand the technology landscape, and (b) Researchers can identify and solve the missing pieces of this puzzle, so that we are ready to face the rest of the COVID-19 pandemic and any future pandemics. A majority of this discussion is focused on the ability to identify contact between individuals. The questions of ethics, privacy, and security of such contact tracing are briefly mentioned but not discussed in detail.
{"title":"Digital contact tracing","authors":"Amee Trivedi, Deepak Vasisht","doi":"10.1145/3431832.3431841","DOIUrl":"https://doi.org/10.1145/3431832.3431841","url":null,"abstract":"Since the start of the COVID-19 pandemic, technology enthusiasts have pushed for digital contact tracing as a critical tool for breaking the COVID-19 transmission chains. Motivated by this push, many countries and companies have created apps that enable digital contact tracing with the goal to identify the chain of transmission from an infected individual to others and enable early quarantine. Digital contact tracing applications like AarogyaSetu in India, TraceTogether in Singapore, SwissCovid in Switzerland, and others have been downloaded hundreds of millions of times. Yet, this technology hasn't seen the impact that we envisioned at the start of the pandemic. Some countries have rolled back their apps, while others have seen low adoption [12, 17]. Therefore, it is prudent to ask what the technology landscape of contact-tracing looks like and what are the missing pieces. We attempt to undertake this task in this paper. We present a high-level review of technologies underlying digital contact tracing, a set of metrics that are important while evaluating different contact tracing technologies, and evaluate where the different technologies stand today on this set of metrics. Our hope is two fold: (a) Future designers of contact tracing applications can use this review paper to understand the technology landscape, and (b) Researchers can identify and solve the missing pieces of this puzzle, so that we are ready to face the rest of the COVID-19 pandemic and any future pandemics. A majority of this discussion is focused on the ability to identify contact between individuals. The questions of ethics, privacy, and security of such contact tracing are briefly mentioned but not discussed in detail.","PeriodicalId":50646,"journal":{"name":"ACM Sigcomm Computer Communication Review","volume":"5 1","pages":"75 - 81"},"PeriodicalIF":2.8,"publicationDate":"2020-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79481509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"计算机科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：